Berberine reduces the occurrence of neonatal necrotizing enterocolitis by reducing the inflammatory response

  • Authors:
    • Yong Jing
    • Fudong Peng
    • Yufeng Shan
    • Jingkai Jiang
  • View Affiliations

  • Published online on: October 17, 2018     https://doi.org/10.3892/etm.2018.6871
  • Pages: 5280-5285
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Necrotizing enterocolitis (NEC) is a life‑threatening disease that occurs in premature infants. The aim of the present study was to investigate the effects of berberine, an isoquinoline alkaloid mainly used to treat digestive diseases, in a rat model of NEC. NEC models were established in newborn rats via inhalation of N2 for 90 sec every 4 h and oral administration of 4 mg/kg/day lipopolysaccharides on days 0 and 1. Berberine was administered via oral gavage. In the NEC model group, Toll‑like receptor (TLR)4, nuclear factor NF‑κB (NF‑κB), inducible nitric oxide synthase (iNOS), tumor necrosis factor (TNF)‑α, interleukin (IL)‑6 and IL‑10 were upregulated. Symptoms of NEC in the berberine intervention group were significantly relieved, with a clear reduction in the incidence of NEC compared with the NEC group. TLR4, NF‑κB, iNOS, TNF‑α, IL‑6 and IL‑10 expression was decreased following berberine intervention. Furthermore, the expression of mucin‑2 (MUC2) and RNA polymerase σ factor SigA (SIgA) were decreased in the NEC model group and increased following berberine intervention, when compared with the untreated group. It was also demonstrated that the incidence of NEC was reduced following berberine administration, possibly owing to changes in the inflammatory responses. The results of the current study support a potential therapeutic role of berberine for the treatment of NEC.
View Figures
View References

Related Articles

Journal Cover

December-2018
Volume 16 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jing Y, Peng F, Shan Y and Jiang J: Berberine reduces the occurrence of neonatal necrotizing enterocolitis by reducing the inflammatory response. Exp Ther Med 16: 5280-5285, 2018
APA
Jing, Y., Peng, F., Shan, Y., & Jiang, J. (2018). Berberine reduces the occurrence of neonatal necrotizing enterocolitis by reducing the inflammatory response. Experimental and Therapeutic Medicine, 16, 5280-5285. https://doi.org/10.3892/etm.2018.6871
MLA
Jing, Y., Peng, F., Shan, Y., Jiang, J."Berberine reduces the occurrence of neonatal necrotizing enterocolitis by reducing the inflammatory response". Experimental and Therapeutic Medicine 16.6 (2018): 5280-5285.
Chicago
Jing, Y., Peng, F., Shan, Y., Jiang, J."Berberine reduces the occurrence of neonatal necrotizing enterocolitis by reducing the inflammatory response". Experimental and Therapeutic Medicine 16, no. 6 (2018): 5280-5285. https://doi.org/10.3892/etm.2018.6871